US Patent Issued to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'ANGERS, UNIVERSITE DE NANTES, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, SORBONNE UNIVERSITE on Sept. 2 for "Diagnosis, prognosis and treatment of a disease related to a decrease of F. prausnitzii" (French, Spanish Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,405,267, issued on Sept. 2, was assigned to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), UNIVERSITE D'ANGERS (Angers, France), UNIVERSITE DE NANTES (Nantes, France), ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (Paris) and SORBONNE UNIVERSITE (Paris).

"Diagnosis, prognosis and treatment of a disease related to a decrease of F. prausnitzii" was invented by Frederic Altare (Nantes, France), Guillaume Sarrabayrouse (Barcelona, Spain), Harry Sokol (Paris), Emmanuelle Godefroy (Nantes, France) and Francine Jotereau (Nantes, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The ...